Reference
Pharmaceuticals and Medical Devices Agency. Revision of Precautions - Clozapine Internet Document : 3 Jun 2021. Available from: URL: https://www.pmda.go.jp/files/000241003.pdf
Rights and permissions
About this article
Cite this article
Clozapine adverse events: labelling modifications in Japan. Reactions Weekly 1860, 2 (2021). https://doi.org/10.1007/s40278-021-97457-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97457-4